Recreational ecstasy use and the neurotoxic potential of MDMA: current status of the controversy and methodological issues
- PMID: 16753651
- DOI: 10.1080/09595230600657758
Recreational ecstasy use and the neurotoxic potential of MDMA: current status of the controversy and methodological issues
Abstract
The controversy over possible MDMA-induced serotonergic neurotoxicity in human recreational ecstasy users is examined critically in light of recent research findings. Although the designs of such studies have improved considerably since the 1990s, the evidence to date remains equivocal for a number of reasons, including (1) inconsistent findings on the existence and reversibility of persistent ecstasy-related serotonergic and cognitive deficits; (2) lack of clear association between changes in brain imaging measures and functional deficits attributed to MDMA-induced neurotoxicity; (3) the contribution of concomitant cannabis or other drug use to both brain imaging abnormalities and cognitive deficits; (4) methodological shortcomings such as failure to adequately match samples of ecstasy users and controls; (5) the questionable relevance of animal models of MDMA-induced neurotoxicity to typical human patterns of ecstasy use; and (6) the potential role of inherent pre-drug deficits in serotonergic systems, impulse control and executive cognitive function that may predispose to excessive use of drugs including ecstasy. Given the retrospective nature of nearly all studies of ecstasy users to date, the controversy over whether MDMA has ever caused neurotoxicity or cognitive deficit in human ecstasy users is likely to continue for some time without resolution.
Similar articles
-
Mood, cognition and serotonin transporter availability in current and former ecstasy (MDMA) users: the longitudinal perspective.J Psychopharmacol. 2006 Mar;20(2):211-25. doi: 10.1177/0269881106059486. J Psychopharmacol. 2006. PMID: 16510479 Review.
-
The confounding problem of polydrug use in recreational ecstasy/MDMA users: a brief overview.J Psychopharmacol. 2006 Mar;20(2):188-93. doi: 10.1177/0269881106059939. J Psychopharmacol. 2006. PMID: 16510477 Review.
-
MDMA in humans: factors which affect the neuropsychobiological profiles of recreational ecstasy users, the integrative role of bioenergetic stress.J Psychopharmacol. 2006 Mar;20(2):147-63. doi: 10.1177/0269881106063268. J Psychopharmacol. 2006. PMID: 16510474 Review.
-
Neurotoxicity of methylenedioxyamphetamines (MDMA; ecstasy) in humans: how strong is the evidence for persistent brain damage?Addiction. 2006 Mar;101(3):348-61. doi: 10.1111/j.1360-0443.2006.01314.x. Addiction. 2006. PMID: 16499508 Review.
-
Mental disorders in current and former heavy ecstasy (MDMA) users.Addiction. 2005 Sep;100(9):1310-9. doi: 10.1111/j.1360-0443.2005.01180.x. Addiction. 2005. PMID: 16128720
Cited by
-
Memory-related hippocampal functioning in ecstasy and amphetamine users: a prospective fMRI study.Psychopharmacology (Berl). 2013 Feb;225(4):923-34. doi: 10.1007/s00213-012-2873-z. Epub 2012 Sep 23. Psychopharmacology (Berl). 2013. PMID: 23001254 Clinical Trial.
-
Effects of 3,4-methylenedioxymethamphetamine administration on retinal physiology in the rat.PLoS One. 2011;6(12):e29583. doi: 10.1371/journal.pone.0029583. Epub 2011 Dec 27. PLoS One. 2011. PMID: 22216322 Free PMC article.
-
A direct comparison of the behavioral and physiological effects of methamphetamine and 3,4-methylenedioxymethamphetamine (MDMA) in humans.Psychopharmacology (Berl). 2012 Jan;219(1):109-22. doi: 10.1007/s00213-011-2383-4. Epub 2011 Jun 30. Psychopharmacology (Berl). 2012. PMID: 21713605 Free PMC article.
-
Residual neurocognitive features of long-term ecstasy users with minimal exposure to other drugs.Addiction. 2011 Apr;106(4):777-86. doi: 10.1111/j.1360-0443.2010.03252.x. Epub 2011 Feb 15. Addiction. 2011. PMID: 21205042 Free PMC article.
-
Disrupted 'reflection' impulsivity in cannabis users but not current or former ecstasy users.J Psychopharmacol. 2009 Jan;23(1):14-22. doi: 10.1177/0269881108089587. Epub 2008 May 30. J Psychopharmacol. 2009. PMID: 18515464 Free PMC article. Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical